Navigation Links
Perfluoron Liquid

ProductsPerfluoron Liquid
Company Alcon Laboratories
Item Perfluoron Liquid
Features 
  • Certified to be > 99.9 percent pure - the purest perfluorocarbon available.
  • Lowest possible refractive index and low viscosity, making it easy to identify and remove.
  • Highest vapor pressure, to aid in the removal of residual material.
  • Provides gentle traction.
  • High specific gravity, which displaces subretinal fluids for complete retinal flattening and reduction of posterior retinotomy.
  • Optical clarity, eliminating optical reflexes encountered when dissecting under oil.
Description Welcome to a new dimension in vitreoretinal surgery. By using Perfluoron, a liquid tool composed of purified perfluoro-n-octane, you can greatly expand your surgical capabilities. Perfluoron is ideal for managing retinal detachments complicated by proliferative vitreoretinopathy, giant retinal tears and trauma.

Certified to be >99.9 percent pure, Perfluoron is the purest perfluorocarbon available. The purity of cyclic chain perfluorocarbons such as perfluorodecalin (about 95 percent pure) and perfluorophenanthrene cannot be accurately verified because they generate multiple peaks in gas liquid chromatography and nuclear magnetic resonance spectroscopic analysis. However, Perfluoron has a straight chain, which generates a single peak so its purity can be accurately analyzed.

Perfluorons properties make your procedure more efficient, with less risk of subretinal fluids, reducing the need for posterior retinotomy. With the lowest possible refractive index of any other liquid perfluorocarbon, you can easily differentiate Perfluoron from irrigating fluids it does not mix with water, ionic solutions or common organic chemicals. Perfluorons low viscosity causes it to form droplets rather than to spread, making it easy to find and remove. It also has the highest vapor pressure to facilitate removal.

Another advantage of Perfluoron is its optical clarity, which gives you an unobstructed view of retinal structures. Because Perfluoron is optically clear, it also eliminates the optical reflexes encountered when you dissect under oil.

Due to Perfluorons high specific gravity, its tamponading effect is greater than silicone oil to give you unparalleled control. Perfluoron becomes a hydrokinetic tool for opening a funneled retinal detachment in proliferative vitreoretinopathy. It also becomes a third hand for stabilizing the retina for peeling or delamination of epiretinal membranes. Perfluoron provides gentle traction on epiretinal membranes for more precise, efficient procedures.

In addition, the high specific gravity of Perfluoron displaces subretinal fluids so the retina flattens completely. Perfluoron is also ideal for laser surgery because it does not absorb visible light and has a higher boiling point (105C) than irrigating fluid.

Info Alcon Laboratories
Customer Service: (800) 757-9195
Web site: http://www.alconlabs.com/

Related medicine products :

1. BUN Liquidplus Reagent
2. Urea Nitrogen (BUN) Liquid Reagent
3. ALT (GPT) Liquidplus Reagent
4. ALT (SGPT) Liquid Reagent (Kinetic Method)
5. g-GT Liquid Reagent
6. Gama-GT Liquid Reagent
7. Inorganic Phosphorus (Liquid)
8. Glucose Color Liquidplus Reagent
9. Glucose UV Liquidplus
10. Glucose Hexokinase Liquid
11. Glucose (Liquid) Reagent
...smeter is designed for fast & easy operation. The ...ate for everyone., ,In AUTO mode, the readings...aligned. Multi-Focal lenses are automatically dete...o correctly position the lens. The color touch pan...
Pro-lll
FF 450plus Fundus Camera
TRC-50FXC
Medicine Products:
(Date:11/26/2009)...thrill when on an emotional rollercoaster, study f...ws) -- Call it the fear factor meets the jubilant ...ors -- especially those who root for the winning t...losely contested match and victory was in doubt, p...Chew on that this Thanksgiving weekend as you,re g...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Cente...las , is one of a growing number of physicians who...g sites to connect with individuals who are intere...rbid obesity. Dr. Kim is utilizing Facebook to sha...is practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly e... for retailers struggling to make an economic reco...26, 2009 -- Flu fears is the type of challenge tha... room, according to Dr. David Benton, business gro...ss growth system – The Rfactor Intensive . ...
(Date:11/25/2009)....,Nov.25/PRNewswire-USNewswire/--Whenmostpeoplehea...actorcanalsogivepatientsthehelptheyneed.TMJstandsf...mandible)contacts/connectswithyourskull(temporalbo...ysfunctionarepainwithchewing,clickingorpoppingofth...tionincluding:headaches,fatigue,sleepdisturbances,...
(Date:11/25/2009)...,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharma...companywillhosttwoinvestoreventsinDecember: ,, ...10:00a.m.ET ,, Principalinvestigatorswilldisc...edand/orrefractorymultiplemyeloma,asfeaturedatthe5...dExpositioninNewOrleans,LA.Theteleconferencewillbe...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...disease is a neurodegenerative disease of the subs...sease was // first discovered and its symptoms doc... Parkinson and the associated biochemical changes ...study done recently it was seen that a drug previo...
...eight at the period of gestation has a profound ef...t has been found // that although children even if... 50% risk towards psychological distress in their ...il recently it has been unclear whether the effect...
...court hearing over nimesulide, a controversial non...dia to treat // fever and pain the health ministry...ia’s drug regulatory agency and not evaluated for ...llenging the use of nimesulide among children. The...
...feel that heart failure can be an important clinic...oblems in // the older population. In a stud... Massachusetts Medical School say that ageing popu... revealed that of the total patients studied who w...
... been used for prevention of pregnancy for decades...ver a recent study indicates that wearing a condom...ction against other sexually transmitted diseases,...o many. Current surveys indicate that approx. 12 m...
...vey on bipolar disorder conducted by the World Fed... the // disease feel that their quality of life su...der is a psychotic disorder characterized by succe...ic condition and most of the sufferers have multip...
Other Medicine News:Health News:Re –growing Brain cells destroyed by Parkinson’s disease 2Health News:Is low birth weight related to psychological distress in adulthood? 2Health News:Condoms May not be safe Enough 2
(Date:11/25/2009)...RINCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharma...calcompanycommittedtodiscovering,developingandcomm...edfinancialresultsforthefiscalyearendedSeptember30...incash,cashequivalentsandshortterminvestments. ,... ,, Phase2bTrial ,, InlateNovember2009,...
(Date:11/25/2009)...RIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedt...blets,anon-nucleosidereversetranscriptaseinhibitor...edforuseintreatment-experiencedadultswhoareexperie...NNRTIandotherantiretroviral(ARV)agents.Thetraditio...sknownasDUET-1andDUET-2.INTELENCEiscurrentlymarket...
(Date:11/25/2009)...ASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBioscie...ntithromboticaptamerswithactivecontrolagents,annou...ntingatthePiperJaffray21stAnnualHealthCareConferen...resentationwillbegivenat1:10pm(EST)onTuesday,Decem...withemphasisontheleaddevelopmentprogram,theanticoa...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10 Q Filing 13726 1Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10 Q Filing 13726 2Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10 Q Filing 13726 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 1Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 4Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 5Boston Scientific Announces Schedule for European Society of Cardiology Congress 4909 6Steady Improvements Seen for Young Blood Cancer Patients 55572 1Steady Improvements Seen for Young Blood Cancer Patients 55572 2